How to Manage Campaign Manufacturing After Product Strength Change


Published on 04/05/2026

Managing Changes in Product Strength During Campaign Manufacturing

In the pharmaceutical manufacturing industry, managing product strength changes during campaign manufacturing presents unique challenges and risks. These changes can significantly impact product quality, safety, and regulatory compliance. This article provides practical, step-by-step guidance to effectively manage these risks, helping manufacturing professionals ensure operational integrity and compliance.

After reading this article, you will be equipped with a comprehensive framework for identifying symptoms, implementing immediate containment actions, conducting thorough investigations, and deploying effective Corrective and Preventive Actions (CAPA) to manage campaign manufacturing risks associated with product strength changes.

1) Symptoms/Signals on the Floor or in the Lab

Identifying early symptoms of issues during campaign manufacturing is crucial to mitigating risks associated with product strength changes. Symptoms may manifest in various forms, including:

  • Deviations in potency: Variability seen in batch potency results, especially if they deviate from specifications set in the batch record.
  • Out-of-specification (OOS) results: Any OOS results observed during in-process or final product testing.
  • Inconsistent physical attributes: Changes in tablet weight, size, or color during the campaign.
  • Quality complaints: An increase in customer complaints regarding
perceived quality or efficacy.
  • Cross-contamination signs: Detected contamination through environmental monitoring or product testing.
  • Recognizing these symptoms promptly enables quick action to contain potential deviations in product quality.

    2) Likely Causes

    Understanding the causes of issues that can arise during campaign manufacturing is essential for an effective resolution. Causes can generally be categorized as follows:

    Materials

    • Variability in raw material quality, suppliers, or batches.
    • Changes in excipient properties due to weight or batch differences.

    Method

    • Inconsistent or improperly performed mixing, granulation, or compression processes.
    • Changes in analytical methods leading to discrepancies.

    Machine

    • Equipment malfunction or improper calibration affecting the production process.
    • Misalignment or wear of parts that can affect product uniformity.

    Man

    • Operator errors or discrepancies in following SOPs.
    • Insufficient training on new processes related to product strength changes.

    Measurement

    • Inaccurate measurement tools or methods leading to incorrect assumptions about product quality.
    • Lack of statistically relevant data for understanding process capability.

    Environment

    • External factors such as temperature or humidity fluctuations in the manufacturing environment.
    • Suboptimal cleaning or maintenance conditions leading to contamination risks.

    Evaluating these categories can help guide the investigation and pinpoint potential failure modes.

    3) Immediate Containment Actions (first 60 minutes)

    Rapid containment is imperative in minimizing risk when symptoms of campaign manufacturing risks are identified. The following actions should be taken within the first 60 minutes:

    1. Cease manufacturing: Immediately halt the production line to prevent further batches from being affected.
    2. Segregate affected materials: Isolate any materials suspected of being contaminated or non-compliant with quality standards.
    3. Initiate quarantine protocols: Place all affected batches under quarantine while conducting an investigation.
    4. Inform key stakeholders: Notify QA, regulatory affairs, and production management to ensure visibility and alignment on the next steps.
    5. Review batch records: Gather all relevant batch records and documentation for the affected production lot for a preliminary data assessment.

    These steps will minimize potential product loss or risk from further processing while enabling information collection for a detailed investigation.

    4) Investigation Workflow (data to collect + how to interpret)

    Conducting a structured investigation is crucial in determining the root cause of the issue and necessary corrective actions. Follow these steps to gather and interpret data effectively:

    1. Document the incident: Create a detailed report capturing all known facts, timeline of events, individuals involved, and initial symptoms observed.
    2. Collect data: Gather quantitative and qualitative data from batch records, testing results, environmental monitoring data, and equipment logs.
    3. Identify patterns: Review collected data for patterns or correlations between symptoms and potential causes. Consider using a simple table format to summarize findings:
    Symptom Potential Cause Data Source Action
    OOS Potency Variability in raw material Raw material certificate of analysis (CoA) Verify supplier batch details
    Inconsistent Tablet Weight Equipment calibration issue Calibration log Re-calibrate equipment
    1. Engage cross-functional teams: Include quality, production, engineering, and regulatory experts in the discussion to broaden the analysis perspective.
    2. Formulate a hypothesis: Based on data analysis, develop hypotheses about root causes that need testing or validation.

    Through this structured approach, teams will be better equipped to interpret critical data and identify root causes effectively.

    5) Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

    Using appropriate root cause analysis tools is vital for effectively understanding the underlying issues behind deviations. Here is a brief overview of three commonly used tools and their application:

    5-Why Analysis

    The 5-Why method encourages teams to ask “why” repeatedly (five times) until the root cause is determined. This method is best used when the issue is relatively simple and quickly understood, enabling a straightforward walk-down of cause-and-effect relationships.

    Fishbone Diagram (Ishikawa)

    This visual tool categorizes potential causes into various groups (Materials, Method, Machine, Man, Measurement, Environment). It is particularly useful for complex issues where multiple factors may be contributing to the problem, allowing for a broad examination of all aspects.

    Fault Tree Analysis

    A top-down approach, fault tree analysis allows teams to construct a diagram that links identified problems back to their origins. This method is particularly effective for highly complex issues and is useful when formal collaboration with regulatory agencies is needed for deeper regulatory compliance discussions.

    Select the tool that best fits the complexity and context of the issue being addressed to facilitate efficient root cause identification.

    6) CAPA Strategy (Correction, Corrective Action, Preventive Action)

    Establishing a robust CAPA strategy is crucial to ensuring that identified issues are effectively addressed. Here’s how to implement a comprehensive CAPA plan:

    Correction

    Immediate actions taken to address the non-conformity. This includes recalling affected batches, notifying stakeholders, or temporarily halting processes until further analysis occurs.

    Related Reads

    Corrective Action

    Long-term actions aimed at addressing the root cause to prevent recurrence. This may involve revising SOPs, retraining personnel, or upgrading equipment based on findings from the root cause analysis.

    Preventive Action

    Strategies that proactively address potential future issues. This could include more frequent quality audits, implementation of enhanced cleaning validation protocols, strict adherence to batch sequencing methodologies, or risk assessments of incoming materials.

    Document all CAPA actions meticulously to satisfy regulatory expectations and to create an auditable trail showcasing compliance efforts.

    7) Control Strategy & Monitoring (SPC/Trending, Sampling, Alarms, Verification)

    Implementing a robust control strategy and monitoring system is vital for ensuring ongoing compliance and quality assurance. Follow these steps:

    1. Statistical Process Control (SPC): Adopt SPC techniques to monitor critical process parameters and keep them within defined control limits. This data can help identify trends indicating potential issues.
    2. Regular sampling: Ensure routine sampling of critical points in the manufacturing process for in-process testing and validating product attributes.
    3. Alarms and alerts: Set up real-time alarms for deviations in critical quality attributes, allowing for instantiation of immediate containment actions if necessary.
    4. Verification: Conduct periodic reviews of all controls in place to ensure they remain effective and to validate any adjustments in process or materials.

    An established, data-driven control strategy enhances not only product quality but also regulatory readiness.

    8) Validation / Re-qualification / Change Control Impact (when needed)

    Changes in product strength may necessitate a re-evaluation of previously validated processes or equipment. Consider the following steps:

    1. Validation assessment: Determine if the deviation in product strength necessitates validation of processes or re-qualification of equipment.
    2. Change control procedures: Follow formal change control procedures if process deviations impact the established manufacturing process or linked documentation.
    3. Risk assessment: Conduct a risk assessment to identify potential impacts on existing validation and qualification status.

    Keep appropriate documentation related to these assessments to ensure compliance with regulatory expectations and provide evidence during inspections.

    9) Inspection Readiness: What Evidence to Show

    To ensure inspection readiness, pharma professionals must compile relevant documentation to demonstrate compliance and responsible management of campaign manufacturing risks. Required evidence includes:

    • Batch records: Up-to-date documentation for all affected batches, including test results, deviations, and corrective actions.
    • CAPA documentation: Detailed records of the CAPA process, including identification of issues, implementation of actions, and any identified effectiveness checks.
    • Change control documentation: Complete records of any changes made to processes, equipment, validations, or personnel training as a result of the investigation.
    • Environmental monitoring logs: Up-to-date data showing compliance with environmental controls and risk management measures.

    Maintain these records in an easily retrievable manner to facilitate quick access and transparency during inspections.

    FAQs

    What should I do first if I suspect contamination due to a product strength change?

    Immediately stop the manufacturing process, segregate affected materials, and notify relevant stakeholders to initiate containment actions.

    What kinds of data should I collect during an investigation?

    Collect data from batch records, testing results, equipment logs, and any relevant environmental monitoring data.

    How do I determine if a product strength change necessitates a new validation?

    If the change affects established manufacturing processes or validated equipment parameters, a re-validation or re-qualification is typically required.

    What is included in a Control Strategy for managing campaign manufacturing risks?

    A control strategy should involve regular monitoring (SPC), sampling procedures, real-time alarms for deviations, and periodic verification of control measures.

    How can I ensure my CAPA strategy is effective?

    Document all actions taken, regularly review and update your processes based on findings, and ensure thorough training and communication across teams.

    What does ‘Immediate Containment’ mean in this context?

    Immediate containment refers to the prompt actions taken to isolate affected materials and halt production to prevent further issues from escalating.

    How do I prevent cross-contamination during campaign manufacturing changes?

    Implement robust cleaning validation protocols and adhere to strict batch sequencing to minimize the risk of cross-contamination.

    What documentation is critical for inspection readiness?

    Key documentation includes batch records, CAPA records, change control logs, and environmental monitoring results, all kept up to date and organized.

    Pharma Tip:  How to Prevent Residue Accumulation in Transfer Lines During Campaigns